CLNT [Cleantech Solutions International,] 8-K: (Original Filing)

[For more information, pleasentact:mpanyntact: Investor Relationsntact: Ms. Teresa Zhang Mr. Athan Dounis Chief Financial Officer CCG Investor Relations China Wind Systems, Tel:+1-646-213-1916 Tel:+1-877-224-6696 x705 Email: athan.dounis@ccgir.com Email:teresa.zhang@chinawindsystems.com Web:http://www.ccgirasia.com Web:http://www.chinawindsystems.com China Wind Systems Receivesnditional Purchasentract to Supply Precisionmponents for Solar Cell Manufacturing Equipment CWS]

CLNT [Cleantech Solutions International,] 8-K: For more information, pleasentact:mpanyntact: Investor Relationsntact: Ms. Teresa

[For more information, pleasentact:mpanyntact: Investor Relationsntact: Ms. Teresa Zhang Mr. Athan Dounis Chief Financial Officer CCG Investor Relations China Wind Systems, Tel:+1-646-213-1916 Tel:+1-877-224-6696 x705 Email: athan.dounis@ccgir.com Email:teresa.zhang@chinawindsystems.com Web:http://www.ccgirasia.com Web:http://www.chinawindsystems.com China Wind Systems Receivesnditional Purchasentract to Supply Precisionmponents for Solar Cell Manufacturing Equipment CWS]

NOAH [Noahs] 424B4: (Original Filing)

[PROSPECTUS 8,400,000 American Depositary Shares NOAH HOLDINGS LIMITED Representing 4,200,000 Ordinary Shares This is the initial public offering of American depositary shares, or ADSs, of Noah Holdings Limited. We are selling 8,400,000 ADSs. Two ADSs represent one ordinary share, par value $0.0005 per share. We have granted the underwriters an option to purchase up to 1,260,000 additional ADSs to cover]

By | 2016-03-03T09:42:01+00:00 November 10th, 2010|Categories: Chinese Stocks, NOAH, SEC Original|Tags: , , , , , |0 Comments

NOAH [Noahs] 424B4: PROSPECTUS 8,400,000 American Depositary Shares NOAH HOLDINGS LIMITED

[PROSPECTUS 8,400,000 American Depositary Shares NOAH HOLDINGS LIMITED Representing 4,200,000 Ordinary Shares This is the initial public offering of American depositary shares, or ADSs, of Noah Holdings Limited. We are selling 8,400,000 ADSs. Two ADSs represent one ordinary share, par value $0.0005 per share. We have granted the underwriters an option to purchase up to 1,260,000 additional ADSs to cover]

By | 2016-03-03T09:43:36+00:00 November 10th, 2010|Categories: Chinese Stocks, NOAH, Webplus ver|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract Employer: Hainan Helpson Medical & Biotechnology Co., Ltd. (hereunder called Party A or Company) Zhilin Li Legal Representative/ authorised agent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A's address: 570216 Post Code: Zhilin Li (hereunder called Party B) Employee: Female Sex: 57 Age: Bachelor Education Level:] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321093010.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322093010.htm]

By | 2016-03-03T20:13:45+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, SEC Original|Tags: , , , , , |0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x September 30, 2010

[FORM 10-Q (Mark One) x September 30, 2010 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC. Delaware 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86 898-6681-1730 (China) (Issuer's telephone number, including area code)] [Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract Employer: Hainan Helpson Medical & Biotechnology Co., Ltd. (hereunder called Party A or Company) Zhilin Li Legal Representative/ authorised agent: Unit 8, D Area, Office Hall, Haikou Bonded Zone, Haikou Party A's address: 570216 Post Code: Zhilin Li (hereunder called Party B) Employee: Female Sex: 57 Age: Bachelor Education Level:] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 -------------------------------- President and Chief Executive Officer EX-32.1 5 cphi10qex321093010.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: November 10, 2010 --------------------- (principal financial officer and principal accounting officer) EX-32.2 6 cphi10qex322093010.htm]

By | 2016-03-03T20:14:44+00:00 November 10th, 2010|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar